about
Anthocyanin-rich purple corn extract inhibit diabetes-associated glomerular angiogenesisAngiopoietin-4 inhibits angiogenesis and reduces interstitial fluid pressureIP-10 induces dissociation of newly formed blood vesselsFoxc2 transcription factor: a newly described regulator of angiogenesisAnti-angiogenic alternatives to VEGF blockadeGene expression analysis of Tek/Tie2 signaling.Acute tumour response to a bispecific Ang-2-VEGF-A antibody: insights from multiparametric MRI and gene expression profiling.Identification of signaling systems in proliferating and involuting phase infantile hemangiomas by genome-wide transcriptional profilingAntivascular therapy for epithelial ovarian cancer.Angiopoietin-2: development of inhibitors for cancer therapy.Antisense angiopoietin-1 inhibits tumorigenesis and angiogenesis of gastric cancer.Evaluation of tumor microenvironment in an animal model using a nanoparticle contrast agent in computed tomography imagingCardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines.Clinical outcome, proteome kinetics and angiogenic factors in serum after thermoablation of colorectal liver metastases.Angiopoietin and vascular endothelial growth factor expression in colorectal disease models.Correlation of microRNA-16, microRNA-21 and microRNA-101 expression with cyclooxygenase-2 expression and angiogenic factors in cirrhotic and noncirrhotic human hepatocellular carcinomaHigh bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromesHypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis.Inhibition of endothelial/smooth muscle cell contact loss by the investigational angiopoietin-2 antibody MEDI3617.Inflammation and breast cancer. Microenvironmental factors regulating macrophage function in breast tumours: hypoxia and angiopoietin-2.Angiopoietin-1 improves endothelial progenitor cell-dependent neovascularization in diabetic wounds.The Role of Macrophage in the Pathogenesis of Brain Arteriovenous Malformation.Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells.Soluble angiopoietin-2/sTie2 receptor ratio is an independent prognostic marker in adult acute myeloid leukemia.Angiogenesis in implantationThe dynamic roles of angiopoietins in tumor angiogenesis.Angiopoietins and angiopoietin-like proteins in angiogenesis.Novel germline variants identified in the inner mitochondrial membrane transporter TIMM44 and their role in predisposition to oncocytic thyroid carcinomasTherapeutic options to target angiogenesis in human malignancies.Potential therapeutic strategies for lymphatic metastasis.The angiopoietin/Tie2 axis mediates malignant pleural effusion formationHyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell deathPreeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2.Clinical Trials of Antiangiogenesis Therapy on Gastric Cancer.MiR-124-5p inhibits the growth of high-grade gliomas through posttranscriptional regulation of LAMB1.The interplay between hypoxia, endothelial and melanoma cells regulates vascularization and cell motility through endothelin-1 and vascular endothelial growth factor.Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden.Targeting angiopoietin-2 signaling in cancer therapy.Phase II angiogenesis stimulators.Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
P2860
Q21132429-E33E03EE-1E1E-492C-A8FB-64F99328EFB8Q24294359-CC27E47B-97F4-4D07-AF89-6E67385A7A00Q24314328-1A4819FB-68E6-4AF5-BA5A-69F1E800E36FQ24653645-B1230209-4621-4AFF-B5BC-481A3A4201DBQ26775947-7831AF8F-8398-41AC-8B81-1DD9C71733D1Q30784372-0EFD5C41-5E95-4DED-967B-959256F70AA7Q31121875-CBE9C643-1DE2-438B-B862-FCBE353CF9EBQ33427340-AC6369C0-6DE4-4933-B5D4-1E3E873CE6B7Q33583598-8A9C8C5D-6B2D-4352-ADC4-3D9BFCBC47ACQ33839423-FD7F3EDF-7027-4B6E-B286-785DCA1932A2Q33868913-0C65D710-E29E-4913-8E63-D9B351AB6FB8Q34470473-353C3234-AB77-420C-8CCE-5ABD9A4333F4Q34698821-5F1D43E9-6092-4E56-9B64-6937DD67ACF9Q34747786-4CEB264B-897E-4B0F-8AD0-76C40327171DQ35152318-6EEFDF0E-9AE9-47D4-B46E-F4672DD5E92EQ35156115-0F915977-D7D4-442A-B2EB-A466B291E257Q35263145-B9A2C0E5-0ECA-4D96-A1FE-CD787FE4536DQ35800467-FE45DE6F-18C5-4A1B-A6B9-26890DB24B67Q35881597-72936088-B42F-4169-8E82-CD70C6042285Q35906308-86015D16-E445-4744-985C-455E942006DAQ35995364-2AE94750-2077-4AE9-A1E0-9BC8023286A7Q36175701-A9E29C8B-B0CF-4B59-A1F3-7D4FF5B1EB93Q36227239-22ABC5A9-1455-4860-BE31-321C8AACBE0DQ36263918-35012787-606A-490C-A42D-15EE8D2F261AQ36268680-AAF1809E-8DE1-4D6D-BAA8-4FDAE6125F16Q36429528-E80834F8-4707-4C30-BA21-F5E5008AACC7Q36489760-C9234D0C-D438-43C0-96B4-AB02019197BCQ36612555-F3AEA007-3942-4139-BC1B-260117D33D37Q36634261-78F8FA06-EEC6-4E10-99A3-AD8FB11507F6Q36851512-D0E5A2CD-5474-4902-8892-8419C7E674D8Q37109566-C03AF1C1-E578-4B1B-889F-2715615C0539Q37401041-883EF5A5-D779-4116-96E9-7BEFB4DCDFE4Q37428029-2DB990E4-FBFF-492D-8C43-C27A1B92FAB7Q37498953-7A99EB8D-E8D8-45B4-99BD-9D9236573F0FQ37699423-4A783183-0566-4C85-87B4-E75F3EFAFE70Q37705532-68576C46-FBDF-4CB9-BF29-46416AB829ADQ37747100-14C9FE5C-3A18-4B44-A553-E68DD9BF5428Q38101997-E2ED220F-BD9A-4479-9BCD-813B73AAA139Q38116090-94FA2242-D71F-492F-BAE4-2FD50ADA98D4Q38498207-CE4933D3-FE7B-4A7C-984B-31EA18643CE6
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Angiopoietins in tumours: the angiogenic switch.
@ast
Angiopoietins in tumours: the angiogenic switch.
@en
type
label
Angiopoietins in tumours: the angiogenic switch.
@ast
Angiopoietins in tumours: the angiogenic switch.
@en
prefLabel
Angiopoietins in tumours: the angiogenic switch.
@ast
Angiopoietins in tumours: the angiogenic switch.
@en
P356
P1476
Angiopoietins in tumours: the angiogenic switch.
@en
P2093
Catherine R Tait
Pamela F Jones
P356
10.1002/PATH.1618
P577
2004-09-01T00:00:00Z